Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Perrigo Company plcNYSE: PRGO
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $322.9M rose 150.1% year over year, ahead of the -271.1% change in trailing-twelve-month EBITDA.
Context
- EBITDA amounted to 18.8% of revenue in FY2025, up 8.9 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 2 analysts of $860.37M (+207.8%) for the fiscal year ending Dec 2026, a step up from the -284.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $322.9M+213.5% QoQ
- Last fiscal yearDec 2025
- -$797.9M-284.3% YoY
- LTMJun 2026
- -$1.05B-271.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +150.1% | +29.0% | -121.1 pp |
| 1 year | -284.3% | +207.8% | +492.1 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (797.9M) USD
- Year-over-year change
- -284.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (797.9M) | -284.3% |
| FY2024 | 2024-12-31 | 433M | -17.5% |
| FY2023 | 2023-12-31 | 525M | +47.7% |
| FY2022 | 2022-12-31 | 355.5M | -48.9% |
| FY2021 | 2021-12-31 | 695.9M | — |
EBITDA vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's LTM Jun 2026 EBITDA of -$1.05B is the lowest of the 10 companies compared; the peer median is -$7.49M.
- Its year-over-year change of -271.1% is the 9th highest of 10, against a peer median of -14.0%.
- EBITDA amounts to 25.2% of revenue for PRGO, versus a peer median of 18.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.05B | -37.3% | +3.4% | 18.9% | |
| LTM Sep 2026 | $667.4M | -18.3% | +7.1% | 19.9% | |
| LTM Sep 2026 | $211.36M | +363.4% | — | 14.0% | |
| LTM Mar 2026 | -$1.36M | +97.4% | — | 0.2% | |
| LTM Jun 2025 | -$7.49M | +93.2% | — | 1.2% | |
| LTM Jun 2026 | -$15.87M | -109.6% | -34.8% | 1.9% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | -$72.16M | +25.1% | — | 30.2% |
| LTM Sep 2026 | -$398.31M | -14.0% | — | 69878.4% | |
| LTM Sep 2026 | -$686.8M | -845.4% | — | 100.7% | |
| LTM Jun 2026 | -$1.05B | -271.1% | — | 25.2% | |
| Peer median (excluding PRGO) | -$7.49M | -14.0% | +3.4% | 18.9% | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.14B | 4.45B | 4.66B | 4.37B | 4.25B |
| Cost of Revenue | 2.72B | 3B | 2.98B | 2.83B | 2.76B |
| Gross Profit | 1.42B | 1.46B | 1.68B | 1.54B | 1.49B |
| Gross Margin | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Research & Development | 122M | 123.1M | 122.5M | 112.2M | 95.4M |
| Selling, General & Admin | 1.11B | 1.21B | 1.27B | 1.11B | 526.5M |
| Operating Expenses | 1.01B | 1.38B | 1.53B | 1.43B | 1.15B |
| Depreciation & Amortization | 312.2M | 338.6M | 359.5M | 325.9M | 337.5M |
| EBITDA | 695.9M | 355.5M | 525M | 433M | (797.9M) |
| EBITDA Margin | 16.8% | 8.0% | 11.3% | 9.9% | -18.8% |
| Operating Income | 410.4M | 78.9M | 151.9M | 112.9M | 343.3M |
| Operating Margin | 9.9% | 1.8% | 3.3% | 2.6% | 8.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 125M | 156M | 173.8M | 187.8M | 162.5M |
| Other Income / Expenses | (151.7M) | (218M) | (160.2M) | (193.6M) | (1.64B) |
| Income Before Tax | 258.7M | (139.1M) | (8.3M) | (80.7M) | (1.3B) |
| Pre-Tax Margin | 6.3% | -3.1% | -0.2% | -1.8% | -30.5% |
| Income Tax Expense | 389.6M | (8.2M) | (3.9M) | 80M | 104.4M |
| Net Income | (68.9M) | (140.6M) | (12.7M) | (171.8M) | (1.43B) |
| Net Margin | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| EPS (Basic) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| EPS (Diluted) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| Weighted Avg Shares | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
| Weighted Avg Shares (Diluted) | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.